Problems of levodopa treatment.
This article reviews the side-effects of levodopa therapy in Parkinson's disease. First the pharmacokinetic aspects of levodopa are dealt with. Then the side-effects are successively discussed. Finally the therapeutic possibilities for the side-effects will be covered. An attempt has been made to give both proponents and opponents of a certain therapy their due to make it clear to the reader that for the time being uniform therapeutic recommendations are not always possible. The typical characteristics and circumstances of every individual patient should be considered before any advice can be given.
D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D004421:Dystonia / Q000139:chemically induced; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D008134:Long-Term Care; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects
D011954:Receptors, Dopamine; D007980:Levodopa; D004298:Dopamine